NCIt definition : An inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential
antineoplastic activity. Upon administration, roblitinib binds to and inhibits the
activity of FGFR4, which leads to an inhibition of tumor cell proliferation in FGFR4-overexpressing
cells. FGFR4 is a receptor tyrosine kinase upregulated in certain tumor cells and
involved in tumor cell proliferation, differentiation, angiogenesis, and survival.;
UNII : M64JF6WMSA;
InChIKey : BHKDKKZMPODMIQ-UHFFFAOYSA-N;
CAS number : 1708971-55-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1708971-55-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;